Abstract
Elevated C-reactive protein (CRP) is associated with enhanced cardiovascular disease risk but the roles of CRP as a participant of the disease process have not been defined. Early endothelial cell injury and dysfunction are recognized events in cardiovascular disease but the initiating events are not well established. Here we tested the hypothesis that recombinant human CRP (rhCRP) can elicit endothelial cell toxicity in-vitro and that the cellular injury is related to intracellular oxidant stress. Human umbilical vein endothelial cells (ECs) were incubated for 48h with rhCRP, or heat denatured recombinant hdCRP (0, 2.5, 5, 10, 20 μg/ml). Intracellular evidence of reactive oxidant species was assessed using 2′,7′-dichlorofluorescin diacetate fluorescence microscopy and cell survival was concurrently determined. rhCRP, but not hd-CRP, caused concentration dependent increases in oxidant production and loss of cell viability (Cell kill – percent of control: 1.3%, 17.8% and 35.2%; rhCRP 2.5, 5 and 10μg/ml). These data demonstrate that rhCRP, at concentrations known to predict adverse vascular outcomes in-vivo, directly causes human endothelial cell toxicity. The ability of CRP to induce reactive oxidant species and to inhibit endothelial cell survival may represent an important mechanism that further links endothelial dysfunction to cardiovascular disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.